🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a randomized phase II clinical trial of patients with histolog...
Status
Completed
Location
Cancer Therapy and Research Center University of Texas Health Science Center San Antonio
Start Date
2015-02-11
Trial ID
NCT02316340
Treatments Being Tested
Open label Phase I study of Regorafenib to evaluate cardiovascular safety, ...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01339104
Treatments Being Tested
Trial evaluating the efficacy of regorafenib combined with irinotecan compa...
Status
Terminated
Location
Institut de Cancérologie de l'Ouest-Paul Papin
Start Date
2019-02-07
Trial ID
NCT03722108
Treatments Being Tested
This is a prospective, non-randomized clinical trial that aims to describe ...
Status
Recruiting
Location
Noordwest ziekenhuisgroep Alkmaar (NWZ)
Start Date
2016-08
Trial ID
NCT02925234
Treatments Being Tested
The purpose of the study is to learn from the real world practice of prescr...
Status
Recruiting
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2016-03-14
Trial ID
NCT02693535
Treatments Being Tested
Regorafenib is an anti-cancer drug that blocks several proteins which are i...
Status
Active Not Recruiting
Location
CHU Lille - Hopital Claude Huriez - Service Gastro-entrologie adulte
Start Date
2024-01-24
Trial ID
NCT06246643
Treatments Being Tested
The FDA and Health Canada have approved regorafenib at a daily dose of 160m...
Status
Withdrawn
Location
Cross Cancer Institute
Start Date
2016-03
Trial ID
NCT02439723
Treatments Being Tested
This is a randomized, multi-center phase II study of ginseng in colorectal ...
Status
Terminated
Location
Indiana Univeristy Melvin and Bren Simon Cancer Center
Start Date
2016-04
Trial ID
NCT02581059
Treatments Being Tested
The purpose of this study is to assess if Regorafenib in combination with b...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01584830
Treatments Being Tested
This is an observational study in which data from patients with metastatic ...
Status
Completed
Location
Many locations
Start Date
2022-08-15
Trial ID
NCT05551039
Treatments Being Tested